# A Study of NWY001 in Subjects With Advanced Solid Tumors

> **NCT05979155** · PHASE1 · RECRUITING · sponsor: **Chipscreen Biosciences, Ltd.** · enrollment: 196 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** NWY001
- **BIOLOGICAL:** NWY001

## Key facts

- **NCT ID:** NCT05979155
- **Lead sponsor:** Chipscreen Biosciences, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-05
- **Primary completion:** 2026-01
- **Final completion:** 2028-05
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05979155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05979155, "A Study of NWY001 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05979155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*